» Articles » PMID: 21502079

High Frequency, Sustained T Cell Responses to PARV4 Suggest Viral Persistence in Vivo

Overview
Journal J Infect Dis
Date 2011 Apr 20
PMID 21502079
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Parvovirus 4 (PARV4) is a recently identified human virus that has been found in livers of patients infected with hepatitis C virus (HCV) and in bone marrow of individuals infected with human immunodeficiency virus (HIV). T cells are important in controlling viruses but may also contribute to disease pathogenesis. The interaction of PARV4 with the cellular immune system has not been described. Consequently, we investigated whether T cell responses to PARV4 could be detected in individuals exposed to blood-borne viruses.

Methods: Interferon γ (IFN-γ) enzyme-linked immunospot assay, intracellular cytokine staining, and a tetrameric HLA-A*0201-peptide complex were used to define the lymphocyte populations responding to PARV4 NS peptides in 88 HCV-positive and 13 HIV-positive individuals. Antibody responses were tested using a recently developed PARV4 enzyme-linked immunosorbent assay.

Results: High-frequency T cell responses against multiple PARV4 NS peptides and antibodies were observed in 26% of individuals. Typical responses to the NS pools were >1000 spot-forming units per million peripheral blood mononuclear cells.

Conclusions: PARV4 infection is common in individuals exposed to blood-borne viruses and elicits strong T cell responses, a feature typically associated with persistent, contained infections such as cytomegalovirus. Persistence of PARV4 viral antigen in tissue in HCV-positive and HIV-positive individuals and/or the associated activated antiviral T cell response may contribute to disease pathogenesis.

Citing Articles

Study on genotyping and coinfection rate of human parvovirus 4 among the HTLV-I/II infected blood donors in Khorasan Razavi, Iran.

Ramezany H, Kheirandish M, Sharifi Z, Samiee S Heliyon. 2023; 9(11):e21406.

PMID: 37954296 PMC: 10637982. DOI: 10.1016/j.heliyon.2023.e21406.


.

Rastegarpouyani H, Mohebbi S, Hosseini S, Azimzadeh P, Beyraghie S, Sharifian A Gastroenterol Hepatol Bed Bench. 2018; 11(2):138-144.

PMID: 29910855 PMC: 5990921.


The (gradual) rise of memory inflation.

Klenerman P Immunol Rev. 2018; 283(1):99-112.

PMID: 29664577 PMC: 5947157. DOI: 10.1111/imr.12653.


Adenoviral vaccine induction of CD8+ T cell memory inflation: Impact of co-infection and infection order.

Lee L, Bolinger B, Banki Z, de Lara C, Highton A, Colston J PLoS Pathog. 2017; 13(12):e1006782.

PMID: 29281733 PMC: 5760110. DOI: 10.1371/journal.ppat.1006782.


PARV4 prevalence, phylogeny, immunology and coinfection with HIV, HBV and HCV in a multicentre African cohort.

Sharp C, Gregory W, Hattingh L, Malik A, Adland E, Daniels S Wellcome Open Res. 2017; 2:26.

PMID: 28497124 PMC: 5423528. DOI: 10.12688/wellcomeopenres.11135.1.


References
1.
Sharp C, Vermeulen M, Nebie Y, Djoko C, LeBreton M, Tamoufe U . Changing epidemiology of human parvovirus 4 infection in sub-Saharan Africa. Emerg Infect Dis. 2010; 16(10):1605-7. PMC: 3294412. DOI: 10.3201/eid1610.101001. View

2.
Stone S, Price P, French M . Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection: correlation with protection from CMV disease. J Antimicrob Chemother. 2006; 57(4):585-8. DOI: 10.1093/jac/dkl049. View

3.
Fryer J, Lucas S, Padley D, Baylis S . Parvoviruses PARV4/5 in hepatitis C virus-infected patient. Emerg Infect Dis. 2007; 13(1):175-6. PMC: 2725819. DOI: 10.3201/eid1301.061358. View

4.
Ding C, Urabe M, Bergoin M, Kotin R . Biochemical characterization of Junonia coenia densovirus nonstructural protein NS-1. J Virol. 2001; 76(1):338-45. PMC: 135713. DOI: 10.1128/jvi.76.1.338-345.2002. View

5.
Lalvani A, Brookes R, Hambleton S, Britton W, Hill A, McMichael A . Rapid effector function in CD8+ memory T cells. J Exp Med. 1997; 186(6):859-65. PMC: 2199056. DOI: 10.1084/jem.186.6.859. View